Besides its physiological induction, FGF21 is also elevated in pathological conditions, such as obesity, insulin resistance, or liver diseases, and impairment in FGF21 signaling in these cases has also been also described [43,141,181]. This evidence concerns the gene FGF21 and obesity due to melanocortin 4 receptor deficiency.